Research Site 52 — New York, New York

Research Site 52 is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site 52 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypertriglyceridemia.

Sponsors: Arrowhead Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 52?

Research Site 52 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 52 conducted?

Research Site 52 has 1 clinical trials on record, with 1 currently active. Their work covers Hypertriglyceridemia.

Is Research Site 52 accredited by Crixeo Health?

Research Site 52 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 52?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.